India · Delayed Price · Currency is INR Indoco Remedies Statistics
Total Valuation
Indoco Remedies has a market cap or net worth of INR 18.68 billion. The enterprise value is 28.42 billion.
| Market Cap | 18.68B |
| Enterprise Value | 28.42B |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | Sep 4, 2025 |
Share Statistics
| Current Share Class | 92.30M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +13.56% |
| Shares Change (QoQ) | +17.39% |
| Owned by Insiders (%) | 22.34% |
| Owned by Institutions (%) | 20.86% |
| Float | 36.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 71.66 |
| PS Ratio | 1.06 |
| PB Ratio | 1.92 |
| P/TBV Ratio | 2.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -24.96 |
| EV / Sales | 1.62 |
| EV / EBITDA | 27.57 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.03 |
| Debt / EBITDA | 9.69 |
| Debt / FCF | n/a |
| Interest Coverage | -0.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -1.57% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.93M |
| Profits Per Employee | -189,812 |
| Employee Count | 6,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -106.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.60% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -21.60% |
| 50-Day Moving Average | 225.61 |
| 200-Day Moving Average | 268.89 |
| Relative Strength Index (RSI) | 39.55 |
| Average Volume (20 Days) | 3,555 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Indoco Remedies had revenue of INR 17.60 billion and -1.14 billion in losses. Loss per share was -11.75.
| Revenue | 17.60B |
| Gross Profit | 11.96B |
| Operating Income | -306.90M |
| Pretax Income | -1.27B |
| Net Income | -1.14B |
| EBITDA | 984.55M |
| EBIT | -306.90M |
| Loss Per Share | -11.75 |
Balance Sheet
The company has 193.20 million in cash and 9.99 billion in debt, with a net cash position of -9.79 billion.
| Cash & Cash Equivalents | 193.20M |
| Total Debt | 9.99B |
| Net Cash | -9.79B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 9.74B |
| Book Value Per Share | 123.55 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 67.95%, with operating and profit margins of -1.74% and -6.47%.
| Gross Margin | 67.95% |
| Operating Margin | -1.74% |
| Pretax Margin | -7.22% |
| Profit Margin | -6.47% |
| EBITDA Margin | 5.59% |
| EBIT Margin | -1.74% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.10%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.10% |
| Dividend Growth (YoY) | -86.67% |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.56% |
| Shareholder Yield | -13.46% |
| Earnings Yield | -6.10% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 17, 2012. It was a forward split with a ratio of 7.5.
| Last Split Date | May 17, 2012 |
| Split Type | Forward |
| Split Ratio | 7.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |